| NCT01782027 | Cholesterol, HDL|Lipid Metabolism, Inborn Errors|Tangier Disease|LCAT Deficiency|Cholesteryl Ester Transfer Protein (CETP) Deficiency | Drug: 3H-cholesterol bound to albumin | University of Pennsylvania | | 2012-10-01 | 2016-07-29 |
| NCT01958216 | Occlusion of Bile Duct With an External Bile Diversion. | Other: Intravenous injection of deuterated cholesterol diluted in intralipid 20% | Nantes University Hospital | | 2013-09-01 | 2013-10-08 |
| NCT01138787 | Cholesterol Absorption Inhibition. | Dietary Supplement: Reference spread|Dietary Supplement: Placebo spread|Dietary Supplement: Test spread | Unilever R&D|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | | 2010-06-01 | 2011-06-15 |
| NCT02068248 | LDL Cholesterol | Dietary Supplement: Soluble Fibre | St. Michael's Hospital, Toronto | | 2014-01-01 | 2016-11-07 |
| NCT00114634 | Smith-Lemli-Opitz Syndrome | Dietary Supplement: Egg yolk preparation with cholesterol|Dietary Supplement: Egg substitute, without cholesterol | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institutes of Health Clinical Center (CC) | Phase 2 | 2005-06-01 | 2015-12-24 |
| NCT02549144 | Lipids | Dietary Supplement: Low versus high fat/cholesterol diet | Azienda Ospedaliero, Universitaria Pisana | | 2015-12-01 | 2015-11-16 |
| NCT01773278 | Smith-Lemli-Opitz Syndrome|Cone-Rod Dystrophy|Hearing Loss | Drug: Antioxidants|Drug: Cholesterol | University of Colorado, Denver | | 2008-12-01 | 2016-08-18 |
| NCT01356420 | Smith-Lemli-Opitz Syndrome | Dietary Supplement: Cholesterol supplementation | Oregon Health and Science University | | 2011-01-01 | 2012-09-18 |
| NCT01634646 | Overweight|Elevated Cholesterol | Dietary Supplement: Lyzme5 | Jeff Golini|All American Pharmaceutical | | 2012-05-01 | 2013-07-12 |
| NCT01890031 | Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors|Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk Factors | Other: Interactive Cholesterol Advisory Tool|Other: Study physician visits | University of Rochester | Phase 1 | 2012-01-01 | 2015-08-05 |
| NCT00765284 | HDL Cholesterol | | KineMed | | 2007-12-01 | 2011-06-29 |
| NCT01004705 | Elevated LDL Cholesterol | Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),|Drug: Simvastatin | Ferrer Internacional S.A. | Phase 2 | 2009-09-01 | 2012-07-31 |
| NCT00652301 | Cholesterol | Drug: ezetimibe|Drug: Comparator: Placebo (unspecified)|Drug: simvastatin | Merck Sharp & Dohme Corp.|Schering-Plough | Phase 3 | 2003-07-01 | 2017-03-07 |
| NCT02779673 | LDL-cholesterol Level 130-159mg/dL | Other: Yoghurt drink containing plant stanol as esters|Other: Yoghurt drink without plant stanol as esters | Yonsei University | | 2014-07-01 | 2016-05-19 |
| NCT01031862 | Healthy | Other: 3H-Cholesterol | University of Pennsylvania|Bristol-Myers Squibb | | 2009-11-01 | 2010-06-24 |
| NCT01362218 | Elevated LDL Cholesterol | Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)|Drug: Simvastatin, ramipril, acetylsalicylic acid | Ferrer Internacional S.A. | Phase 2 | 2010-10-01 | 2013-04-23 |
| NCT01930149 | Cardiovascular Diseases|Lipid Testing|Primary Prevention of Cardiovascular Disease | Behavioral: Mailed patient outreach intervention | Northwestern University|Agency for Healthcare Research and Quality (AHRQ) | | 2013-12-01 | 2014-09-26 |
| NCT00272844 | Smith-Lemli-Opitz Syndrome | Drug: crystalline cholesterol oil-based suspension | Boston Children鈥檚 Hospital | Phase 1|Phase 2 | 1998-01-01 | 2011-07-13 |
| NCT00999453 | Hypercholesterolemia | Other: LDL-cholesterol | Clinical Research Center for End Stage Renal Disease, Korea|Ministry of Health & Welfare, Korea | | 2009-10-01 | 2017-03-15 |
| NCT00328211 | Healthy | Dietary Supplement: Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic)|Dietary Supplement: Sphingomyelin|Drug: Pluronic F-68|Other: C13 Stable isotope of Cholesterol | Children's Hospital Medical Center, Cincinnati|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | | 2005-09-01 | 2016-12-06 |
